RT Journal
A1 Moore M, Gibbs P
T1 ADjuvant chemotherapy use among older patients with stage iii colon cancer
JF JAMA
JO JAMA
YR 2010
FD June 16
VO 303
IS 23
SP 2353
OP 2354
DO 10.1001/jama.2010.775
UL http://dx.doi.org/10.1001/jama.2010.775
AB 
The authors suggested that the limited use of oxaliplatin, especially for older patients, differs substantially from guidelines. However, current guidelines advise that capecitabine or fluorouracil alone are acceptable treatment options for stage III colon cancer. Furthermore, recent adjuvant studies have failed to demonstrate that adding oxaliplatin is of benefit for older patients,2 and use of this agent in this group remains controversial.